InvestorsObserver
×
News Home

DURECT Corp (DRRX) Stock: What Does the Chart Say Wednesday?

Wednesday, December 07, 2022 09:52 AM | InvestorsObserver Analysts

Mentioned in this article

DURECT Corp (DRRX) Stock: What Does the Chart Say Wednesday?

Overall market sentiment has been high on DURECT Corp (DRRX) stock lately. DRRX receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
DURECT Corp has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on DRRX!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With DRRX Stock Today?

DURECT Corp (DRRX) stock is higher by 6.15% while the S&P 500 is down -0.22% as of 9:50 AM on Wednesday, Dec 7. DRRX has risen $0.22 from the previous closing price of $3.58 on volume of 10,670 shares. Over the past year the S&P 500 has fallen -14.35% while DRRX is down -60.66%. DRRX lost -$0.14 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for DURECT Corp click here.

More About DURECT Corp

Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the United States. Click Here to get the full Stock Report for DURECT Corp stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App